GP leader Dr. Michael Dixon is urging the rewording of proposed legislations of the Health and Social Care act to increase competition within the new NHS setup. According to reports, Dr. Dixon, who is the interim president of NHS Clinical Commissioners, is urging a rewording of a section in the Health and Social Care Act he claims would stifle competition, as the wording forces NHS bodies to use private firms to treat their patients. In a statement, Dixon said, “unless the commissioner is king, the whole system is going to fall down.” The Act will come into effect April 1.
Featured News
Meta Halts Commercial Terms Rollout After Publishers Raise Concerns in EU, UK
Oct 28, 2026 by
CPI
Nvidia’s $12.9 Billion Hugging Face Deal Draws Justice Department Questions
Oct 28, 2026 by
CPI
Rolls-Royce’s UltraFan Wins £2.5 Billion UK Framework Deal
Oct 28, 2026 by
CPI
Taiwan Blocks Grab’s $600 Million Foodpanda Deal, Citing Uber Ties
Oct 28, 2026 by
CPI
South Korea Expands Food Price-Fixing Probe to Four Major Instant Noodle Makers
Oct 28, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Exclusive Dealing
Oct 25, 2026 by
CPI
Exclusive Dealing Without Exclusivity: Screening Contracts, Loyalty Rebates, and the Limits of Antitrust Tests
Oct 25, 2026 by
David Martimort & Jérôme Pouyet
When Competition for Exclusivity Raises Prices: Rebates, Pricing Rules, and the Insulin Puzzle
Oct 25, 2026 by
Daniel P. O’Brien & Greg Shaffer
Why Leaving the Door Open Can Be (Much) Worse Than Closing It: Share-Based Requirements, Buyer-Specific Costs, and Foreclosure
Oct 25, 2026 by
Zhijun Chen & Greg Shaffer
Antitrust Chronicle® – EU Merger Guidelines
Oct 19, 2026 by
CPI